Related Experiment Video
Updated: Mar 23, 2026
03:26
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
3.7K
Future Directions in Pain Management: Integrating Anatomically Selective Delivery Techniques With Novel Molecularly
Josef Pleticha1, Timothy P Maus2, Andreas S Beutler1
1Department of Anesthesiology and Oncology, Mayo Clinic, Rochester, MN.
Mayo Clinic Proceedings
|April 6, 2016
Summary
New gene therapy approaches offer targeted, long-term pain relief for chronic pain conditions, overcoming limitations of current systemic drugs and interventional procedures.
Area of Science:
- Pain management
- Gene therapy
- Interventional procedures
Background:
- Chronic pain is a widespread medical issue with limited effective treatments.
- Systemic analgesics like opioids have significant drawbacks, including toxicity and abuse potential.
- Current interventional pain procedures lack long-term pharmacological efficacy.
Purpose of the Study:
- To explore the potential of gene therapy for developing molecularly selective pain treatments.
- To investigate the integration of gene therapy with image-guided delivery for enhanced pain management.
Main Methods:
- Utilizing gene therapy vectors for targeted delivery of analgesic genes.
- Employing image-guided techniques for precise interventional delivery.
Main Results:
- Preclinical models have demonstrated durable analgesia using gene therapy vectors.
- The combination of gene therapy and interventional delivery shows promise for dual selectivity.
Conclusions:
- Advances in gene therapy and image-guided delivery may create a novel class of dual selective analgesic treatments.
- This approach integrates molecular selectivity of genes with anatomical precision of interventions for improved chronic pain management.
Related Concept Videos
01:25Analgesia and Pain Management
2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.4K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K
01:44Nociception
34.3K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
34.3K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
91
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
91
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
104
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
104